BioCardia, Inc.
BCDA
$0.83
-$0.05-5.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -13.86% | -33.78% | 27.62% | 24.45% | -18.12% |
| Total Depreciation and Amortization | 0.00% | -25.00% | -20.00% | -58.33% | -20.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.36% | 48.33% | -8.63% | -32.30% | -25.38% |
| Change in Net Operating Assets | 146.36% | -109.92% | -288.38% | -74.97% | 245.94% |
| Cash from Operations | 33.56% | -49.34% | -1.39% | -1.92% | 33.50% |
| Capital Expenditure | 50.00% | -- | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 50.00% | -- | 100.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4,400.00% | -99.93% | 300.18% | 699.53% | 443.59% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -12.50% | 88.06% | -5,642.86% | 12.50% | 33.33% |
| Cash from Financing | 140.63% | -104.82% | 255.68% | 757.65% | 256.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 44.64% | -164.80% | 13,793.55% | 102.18% | 44.43% |